Navigation Links
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
Date:5/16/2013

itors have shown long-term efficacy in rheumatoid arthritis studies with an early onset of action.  GLPG0634 differentiates from other JAK inhibitors in development by specifically targeting JAK1, a strategy which could result in a better efficacy and safety profile.  GLPG0634 is a fully proprietary program.  Upon successful completion of the Phase 2b studies in RA, AbbVie will license the program and will assume sole responsibility for Phase 3 clinical development and global manufacturing.

About Crohn's disease
Crohn's disease is a type of inflammatory bowel disease in which the well-controlled balance of the intestinal immune system is disturbed.  The disease causes ulcerations of the small and large intestines in particular, but may affect any part of the digestive system from mouth to anus.  The cause of the disease is unknown, with onset usually between the ages of 15 and 35.  Patients suffer from abdominal pain, diarrhea (often bloody), vomiting, fever, and weight loss.  There is no cure for Crohn's disease; treatment options today are restricted to controlling symptoms, maintaining remission, and preventing relapse by the use of drugs that suppress the inflammation or the immune system, antibiotics, and eventually surgical removal of the inflamed bowels. 

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott.  The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.  In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries.  For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com.  Follow

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
2. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
3. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
4. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
5. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
6. AbbVie Reports First-Quarter 2013 Financial Results
7. AbbVie to Host First-Quarter Earnings Conference Call
8. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
9. AbbVie to Present at Barclays Global Health Care Conference
10. AbbVie Issues Inaugural Full-Year Outlook for 2013
11. AbbVie Named to S&P 500 Dividend Aristocrat Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 Surgeons at The Children,s Hospital of ... report the first successful use of a SynCardia temporary ... with failing Fontan circulation to bridge him to a ... old, the patient received a Fontan circulation procedure to ... "The Fontan operation is the final planned palliative operation ...
(Date:9/16/2014)... 2014   Evana Automation Specialists , a leading ... test systems, recently received a contract to provide a ... The Evana solution will help error-proof the process of ... as reduce labor. A catheter adapter, ... assembly cell. The robot will pick the adapter, connector ...
(Date:9/16/2014)... , Sept. 16, 2014   HemCon Medical ... of TriStar Wellness Solutions(R), Inc. (OTCQB: ... advanced medical products, announced today that the revenue ... by 39 percent, and microdispersed oxidized cellulose raw ... 2014.  Overall, TWSI expects third quarter revenues to ...
Breaking Medicine Technology:13-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 2HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 3HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 4
... Generex Biotechnology Corporation (OTCBB: GNBT) ( www.generex.com ) is ... of developments that have been achieved since the appointment ... on September 29, 2010. "Since my appointment ... have made it a priority to proactively communicate significant ...
... 2, 2011 Perrigo Company (Nasdaq: PRGO;TASE) today announced that ... 2011 on Tuesday, August 16 , 2011 at approximately 8:00 ... 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo,s Chairman ... be available live via webcast to interested parties on the ...
Cached Medicine Technology:Generex Provides Corporate Update 2Generex Provides Corporate Update 3Generex Provides Corporate Update 4Generex Provides Corporate Update 5Generex Provides Corporate Update 6Generex Provides Corporate Update 7Generex Provides Corporate Update 8
(Date:9/16/2014)... 2014 A new study found that fractional ... of true coronary bifurcation lesions yields similar outcomes ... clinical trial is the first study to compare ... reported today at the 26th annual Transcatheter Cardiovascular ... Research Foundation (CRF), TCT is the world,s premier ...
(Date:9/16/2014)... be able to predict when and how much various ... in part to new findings that researchers at Fox ... Radiation Oncology,s 56th Annual Meeting on Tuesday, September 16. ... surveys completed by men diagnosed with prostate cancer, Fox ... changed following each type of treatment, and by how ...
(Date:9/16/2014)... September 16, 2014 Seven heroes who ... world will be honored in New York City on ... ), the only global recognition and funding program that ... by the media as the “Nobel Prize for Child ... created life-changing programs that benefit children in countries around ...
(Date:9/16/2014)... September 16, 2014 AcousticSheep LLC, makers ... to launch RunPhones® Wireless, their latest version of RunPhones® ... sport-style headband for active people seeking a safe, comfortable ... on the market and will be available October ... Wireless has all of the same great features as ...
(Date:9/16/2014)... (HealthDay News) -- Including women older than 70 in ... sharp reduction in advanced forms of the disease, a ... screening programs could result in older women being overdiagnosed ... decision to screen older women for breast cancer should ... "Instead of using mass screening, the decision to participate ...
Breaking Medicine News(10 mins):Health News:Results of DKCRUSH-VI trial reported at TCT 2014 2Health News:Study identifies when and how much various prostate cancer treatments will impact urinary and sexual functioning 2Health News:Study identifies when and how much various prostate cancer treatments will impact urinary and sexual functioning 3Health News:World of Children® Award Announces 2014 Honorees 2Health News:World of Children® Award Announces 2014 Honorees 3Health News:World of Children® Award Announces 2014 Honorees 4Health News:World of Children® Award Announces 2014 Honorees 5Health News:World of Children® Award Announces 2014 Honorees 6Health News:World of Children® Award Announces 2014 Honorees 7Health News:World of Children® Award Announces 2014 Honorees 8Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 2Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 3Health News:Some Benefits of Screening Elderly Women for Breast Cancer Questioned 2
... , SATURDAY, June 20 (HealthDay News) -- Mowing the ... people forget that their lawn mower can cause serious ... States, about 200,000 people (including 16,000 children) are injured ... Product Safety Commission. Those injuries include severed fingers, toes ...
... , WALTHAM, Mass., June 19 I-Therapeutix announced today that ... The round was led by Polaris Venture Partners in ... and SV Life Sciences. , , The ... the United States and to develop sustained drug delivery products ...
... to sign a bill giving the Food and Drug ... study from Harvard School of Public Health (HSPH) researchers ... and the design of their cigarettes over time, even ... The result, say the researchers, is that consumers who ...
... tests find cannabis even more toxic than tobacco, , FRIDAY, ... plant from which marijuana is derived, contains compounds that can ... tobacco smoke, says a new study from the United Kingdom. ... of Leicester and colleagues found certain carcinogens in cannabis smoke ...
... asks for less institutional, more personal care , FRIDAY, ... where residents are free to make choices regarding their ... home, according to a guidance issued Friday by the ... The directives in the CMS guidance aim to "transform ...
... own self be true" may take on a new ... behavior. Plants engage in self-recognition and can communicate ... nearby, says professor Richard Karban of the Department of ... in the current edition of Ecology Letters . ...
Cached Medicine News:Health News:Don't Get Lazy About Lawn-Mower Safety 2Health News:I-Therapeutix, Inc. Closes $15 Million Financing 2Health News:Study finds that tobacco companies changed design of cigarettes without alerting smokers 2Health News:Make Nursing Homes More Like Home: Medicare 2Health News:Plant communication: Sagebrush engage in self-recognition and warn of danger 2
... is precision, ergonomics, and value!, ... with soft non-slip, contoured handle , ... light plunger spring action , Completely ... without the need for recalibration , ...
50L...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: